L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis

Slides:



Advertisements
Similar presentations
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Saurabh Dawra, Vishal Sharma, Usha Dutta 
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure  Stephen J.D. O'Keefe, Palle B. Jeppesen,
Muscle Cramps in Cirrhosis: A Moving Target
Pichamol Jirapinyo, Christopher C. Thompson 
Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure  Stephen J.D. O'Keefe, Palle B. Jeppesen,
Coordinating Care in Patients With Cirrhosis
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
A Shocking Cystory Clinical Gastroenterology and Hepatology
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Phillip S. Ge, MD, Bruce A. Runyon, MD 
Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH 
Issue Highlights Clinical Gastroenterology and Hepatology
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B  Jeong Han Kim, So Young Kwon, Young Sok.
Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C  Pamela S. Belperio, Elizabeth.
Pancreatic Duct Drainage for the Treatment of a Huge Pancreatic Cyst Associated With Autoimmune Pancreatitis  Hiroyuki Matsubayashi, Toru Matsui, Hiroyuki.
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Endoscopy 20 Years Into the Future
Jessica L. Mellinger, Michael L. Volk 
Endoscopic Therapy for Barrett's Esophagus
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Rapid Disappearance of a Pancreatic Cyst After Steroid Therapy in a Patient With Autoimmune Pancreatitis  Terumi Kamisawa, Hajime Anjiki, Naoto Egawa 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima 
Gastroenterology in a New Era of Accountability: Part 2
William D. Leslie  Clinical Gastroenterology and Hepatology 
New Models of Gastroenterology Practice
Efficacy and Safety of a Magnesium Sulfate–Rich Natural Mineral Water for Patients With Functional Constipation  Christophe Dupont, Alain Campagne, Florence.
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
Covering the Cover Gastroenterology
George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B
David H. Bruining, William J. Sandborn 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Patient-Reported Outcomes of Cirrhosis
Issue Highlights Clinical Gastroenterology and Hepatology
Tamir Ben–Menachem, Jason A. Dominitz 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 134, Issue 5, Pages (May 2008)
Alan Bonder, MD, Nezam H. Afdhal, MD 
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
James Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu, James Lowder 
Issue Highlights Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Immune Dysfunction and Infections in Patients With Cirrhosis
Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection  Harald Farnik, Christian M. Lange,
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Patrick Yachimski, William P. Puricelli, Norman S. Nishioka 
Volume 139, Issue 6, Pages e1 (December 2010)
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
Endoscopic Therapy of Jejunal Diphyllobothrium nihonkaiense Infection
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen 
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Kouichi Gondo, Yu Asano, Nobuhiro Hattori, Nobuharu Tamaki, Shoko Suzuki, Yutaka Yasui, Takanori Hosokawa, Jun Itakura, Yuka Takahashi, Namiki Izumi  Clinical Gastroenterology and Hepatology  Volume 13, Issue 8, Pages 1540-1543 (August 2015) DOI: 10.1016/j.cgh.2014.12.005 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Efficacy of L-carnitine treatment for the reduction or disappearance of muscle cramps. Percentages of (A) reduction and (B) disappearance of muscle cramps are shown. Muscle cramping was reduced in 88.1% and disappeared in 28.6% of patients after 8 weeks of therapy. The dose of L-carnitine was an important factor associated with disappearance of muscle cramps. Clinical Gastroenterology and Hepatology 2015 13, 1540-1543DOI: (10.1016/j.cgh.2014.12.005) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 Scores of VAS before and after 8 weeks of L-carnitine treatment are shown. Black and gray lines indicate the 1200 mg group and 900 mg group, respectively. (A) Overall, the mean value of VAS score was reduced significantly from 69.9 ± 22.5 to 26.2 ± 29.1 after 8 weeks of therapy. (B) According to the dose of L-carnitine, VAS scores after 8 weeks of therapy were significantly lower in 1200 mg group than in 900 mg group. Clinical Gastroenterology and Hepatology 2015 13, 1540-1543DOI: (10.1016/j.cgh.2014.12.005) Copyright © 2015 AGA Institute Terms and Conditions